294 related articles for article (PubMed ID: 24366669)
1. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.
Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669
[TBL] [Abstract][Full Text] [Related]
2. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
[TBL] [Abstract][Full Text] [Related]
4. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients.
Calvo-Río V; Blanco R; Beltrán E; Sánchez-Bursón J; Mesquida M; Adán A; Hernandez MV; Hernandez Garfella M; Valls Pascual E; Martínez-Costa L; Sellas-Fernández A; Cordero Coma M; Díaz-Llopis M; Gallego R; Salom D; García Serrano JL; Ortego N; Herreras JM; Fonollosa A; García-Aparicio AM; Maíz O; Blanco A; Torre I; Fernández-Espartero C; Jovani V; Peiteado-Lopez D; Pato E; Cruz J; Fernández-Cid C; Aurrecoechea E; García M; Caracuel MA; Montilla C; Atanes A; Hernandez FF; Insua S; González-Suárez S; Sánchez-Andrade A; Gamero F; Linares L; Romero-Bueno F; García AJ; Almodovar R; Minguez E; Carrasco Cubero C; Olive A; Vázquez J; Ruiz Moreno O; Jiménez-Zorzo F; Manero J; Muñoz Fernández S; Rueda-Gotor J; González-Gay MA
Rheumatology (Oxford); 2014 Dec; 53(12):2223-31. PubMed ID: 24996907
[TBL] [Abstract][Full Text] [Related]
6. INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema.
Lejoyeux R; Diwo E; Vallet H; Saadoun D; Tezenas du Montcel S; Bodaghi B; LeHoang P; Fardeau C
Ocul Immunol Inflamm; 2018; 26(7):991-996. PubMed ID: 30096013
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal adalimumab for refractory uveitis-related macular edema.
Androudi S; Tsironi E; Kalogeropoulos C; Theodoridou A; Brazitikos P
Ophthalmology; 2010 Aug; 117(8):1612-6. PubMed ID: 20378179
[TBL] [Abstract][Full Text] [Related]
8. Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema.
Acharya NR; Sittivarakul W; Qian Y; Hong KC; Lee SM
Retina; 2011 Oct; 31(9):1871-6. PubMed ID: 21716165
[TBL] [Abstract][Full Text] [Related]
9. Infliximab for chronic cystoid macular edema associated with uveitis.
Markomichelakis NN; Theodossiadis PG; Pantelia E; Papaefthimiou S; Theodossiadis GP; Sfikakis PP
Am J Ophthalmol; 2004 Oct; 138(4):648-50. PubMed ID: 15488796
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
[TBL] [Abstract][Full Text] [Related]
11. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U
Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
[TBL] [Abstract][Full Text] [Related]
13. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.
Lasave AF; Zeballos DG; El-Haig WM; Díaz-Llopis M; Salom D; Arevalo JF
Ocul Immunol Inflamm; 2009; 17(6):423-30. PubMed ID: 20001264
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.
Cervantes-Castañeda RA; Giuliari GP; Gallagher MJ; Yilmaz T; MacDonell RE; Quinones K; Foster CS
Eur J Ophthalmol; 2009; 19(4):622-9. PubMed ID: 19551679
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal infliximab for the treatment of sight-threatening chronic noninfectious uveitis.
Farvardin M; Afarid M; Mehryar M; Hosseini H
Retina; 2010 Oct; 30(9):1530-5. PubMed ID: 20924267
[TBL] [Abstract][Full Text] [Related]
16. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
[TBL] [Abstract][Full Text] [Related]
17. Adalimumab therapy for refractory uveitis: a pilot study.
Diaz-Llopis M; García-Delpech S; Salom D; Udaondo P; Hernández-Garfella M; Bosch-Morell F; Quijada A; Romero FJ
J Ocul Pharmacol Ther; 2008 Jun; 24(3):351-61. PubMed ID: 18476805
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients.
Mercier AE; Ribeiro E; Korobelnik JF; Delyfer MN; Rougier MB
Ocul Immunol Inflamm; 2018; 26(3):477-484. PubMed ID: 27775458
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review.
Calvo-Río V; Blanco R; Santos-Gómez M; Díaz-Valle D; Pato E; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA
Ocul Immunol Inflamm; 2017 Oct; 25(5):604-609. PubMed ID: 27726475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
